Fosun International Ltd 13D and 13G filings for Amneal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-24 06:03 am Sale | 2024-03-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Fosun International Ltd | 9,200,603 3.000% | -9,207,053 (-50.02%) | Filing |
| 2023-12-12 06:04 am Unchanged | 2023-11-07 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Fosun International Ltd | 18,407,656 6.000% | 0 (Unchanged) | Filing |
| 2020-02-14 06:59 am Purchase | 2019-12-31 | 13G | Amneal Pharmaceuticals, Inc. AMRX | Fosun International Ltd | 18,407,656 13.700% | 1,969,300 (+11.98%) | Filing |